Cipla has entered into definitive agreements on 15 May 2024 for further investment of upto Rs 26 crore in Achira Labs, an associate company. The follow-on investment shall strengthen Cipla`s partnership with Achira, enabling penetration into business domain of designing, developing and manufacturing microfluidics based PoC immunoassay and molecular assay technologies.Powered by Capital Market - Live News

Cipla announced that the Annual General Meeting(AGM) of the company will be held on 20 August 2024.Powered by Capital Market - Live News

Cipla announced that the Board of Directors of the Company at its meeting held on 10 May 2024, inter alia, have recommended the final dividend of Rs 13 per equity Share (i.e. 650%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Cipla rose 78.64% to Rs 939.04 crore in the quarter ended March 2024 as against Rs 525.65 crore during the previous quarter ended March 2023. Sales rose 7.35% to Rs 6082.37 crore in the quarter ended March 2024 as against Rs 5665.95 crore during the previous quarter ended March 2023.For the full year,net profit rose 47.10% to Rs 4121.55 crore in the year ended March 2024 as against Rs 2801.91 crore during the previous year ended March 2023. Sales rose 13.23% to Rs 25446.63 crore in the year ended March 2024 as against Rs 22473.18 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales6082.375665.95 7 25446.6322473.18 13 OPM %21.6320.72 -24.7222.37 - PBDT1547.601274.01 21 6947.745392.88 29 PBT1259.26927.79 36 5896.724220.77 40 NP939.04525.65 79 4121.552801.91 47 Powered by Capital Market - Live News

Cipla announced that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at manufacturing facility of the Company located in Kurkumbh, Maharashtra, India from 29 April 2024 to 8 May 2024. On conclusion of the inspection, the Company has received 1 inspectional observation in Form 483. Powered by Capital Market - Live News